Pharmacokinetic parameters of HIV-infected patients with tuberculosis

  • Mencho Lamezón
Keywords: HIV, tuberculosis, treatment, infection, Pharmacokinetic, cytochrome

Abstract

The increase in the rifabutin dose from 300 mg to 600 mg was adequate to compensate for the drug interaction with efavirenz in most patients. However, additional studies are needed to characterize optimal treatment regimens for patients with HIV infection and tuberculosis.

Published
2020-03-01